Posted by Michael Wonder on 05 Jul 2025
Teprotumumab for the treatment of patients with thyroid eye disease
2 July 2025 - The Department of Health and Social Care has asked NICE to produce guidance on the use of teprotumumab in the NHS in England.
For the time being, teprotumumab should not be used for the treatment of adults with moderate to severe thyroid eye disease.
